Brief: Athira Pharma Receives Nasdaq Non-Compliance Notice

LeonaBio

18/10/2024 21:07

Oct 18 (Reuters) - Athira Pharma Inc  ATHA.O :
    * ATHIRA PHARMA: RECEIVES NASDAQ NON-COMPLIANCE NOTICE
    * ATHIRA PHARMA: CO HAS UNTIL APRIL 14, 2025, TO REGAIN
COMPLIANCE

Source text for Eikon:  ID:n0000950170-24-115592 
Further company coverage:  ATHA.O 

 ((Reuters.Briefs@thomsonreuters.com;))